-
Something wrong with this record ?
Embryo drop-out rates in preimplantation genetic testing for aneuploidy (PGT-A): a retrospective data analysis from the DoLoRes study
B. Wirleitner, M. Hrubá, M. Schuff, L. Hradecký, A. Stecher, A. Damko, J. Stadler, D. Spitzer, M. Obkircher, M. Murtinger
Language English Country Netherlands
Document type Multicenter Study, Journal Article
NLK
Free Medical Journals
from 2008 to 1 year ago
PubMed Central
from 1997 to 1 year ago
Europe PubMed Central
from 1997 to 1 year ago
ProQuest Central
from 1999-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1999-01-01 to 1 year ago
Public Health Database (ProQuest)
from 1999-01-01 to 1 year ago
- MeSH
- Aneuploidy MeSH
- Blastocyst pathology MeSH
- Genetic Testing methods MeSH
- Humans MeSH
- Preimplantation Diagnosis * methods MeSH
- Retrospective Studies MeSH
- Pregnancy MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
PURPOSE: To evaluate the decline in transferable embryos in preimplantation genetic testing for aneuploidy (PGT-A) cycles due to (a) non-biopsable blastocyst quality, (b) failure of genetic analysis, (c) diagnosis of uniform numerical or structural chromosomal aberrations, and/or (d) chromosomal aberrations in mosaic constitution. METHODS: This retrospective multicenter study comprised outcomes of 1562 blastocysts originating from 363 controlled ovarian stimulation cycles, respectively, 226 IVF couples in the period between January 2016 and December 2018. Inclusion criteria were PGT-A cycles with trophectoderm biopsy (TB) and next generation sequencing (NGS). RESULTS: Out of 1562 blastocysts, 25.8% were lost due to non-biopsable and/or non-freezable embryo quality. In 10.3% of all biopsied blastocysts, genetic analysis failed. After exclusion of embryos with uniform or chromosomal aberrations in mosaic, only 18.1% of those originally yielded remained as diagnosed euploid embryos suitable for transfer. This translates into 50.4% of patients and 57.6% of stimulated cycles with no euploid embryo left for transfer. The risk that no transfer can take place rose significantly with a lower number of oocytes and with increasing maternal age. The chance for at least one euploid blastocyst/cycle in advanced maternal age (AMA)-patients was 33.3% compared to 52.1% in recurrent miscarriage (RM), 59.8% in recurrent implantation failure (RIF), and 60.0% in severe male factor (SMF). CONCLUSIONS: The present study demonstrates that PGT-A is accompanied by high embryo drop-out rates. IVF-practitioners should be aware that their patients run a high risk of ending up without any embryo suitable for transfer after (several) stimulation cycles, especially in AMA patients. Patients should be informed in detail about the frequency of inconclusive or mosaic results, with the associated risk of not having an euploid embryo available for transfer after PGT-A, as well as the high cost involved in this type of testing.
Next Fertility Eubios Fossato Molini 9 39012 Merano Italy
Next Fertility IVF Prof Zech Innsbrucker Bundesstrasse 35 5020 Salzburg Austria
Next Fertility IVF Prof Zech Roemerstrasse 2 6900 Bregenz Austria
Next Fertility IVF Prof Zech Smetany 2 30100 Pilsen Czech Republic
Next Fertility St Gallen Kürsteinerstrasse 2 9015 St Gallen Switzerland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007817
- 003
- CZ-PrNML
- 005
- 20240423160308.0
- 007
- ta
- 008
- 240412s2024 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10815-023-02976-9 $2 doi
- 035 __
- $a (PubMed)37878220
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Wirleitner, Barbara $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria. Barbara.wirleitner@ivf.at $1 https://orcid.org/0009000389762561
- 245 10
- $a Embryo drop-out rates in preimplantation genetic testing for aneuploidy (PGT-A): a retrospective data analysis from the DoLoRes study / $c B. Wirleitner, M. Hrubá, M. Schuff, L. Hradecký, A. Stecher, A. Damko, J. Stadler, D. Spitzer, M. Obkircher, M. Murtinger
- 520 9_
- $a PURPOSE: To evaluate the decline in transferable embryos in preimplantation genetic testing for aneuploidy (PGT-A) cycles due to (a) non-biopsable blastocyst quality, (b) failure of genetic analysis, (c) diagnosis of uniform numerical or structural chromosomal aberrations, and/or (d) chromosomal aberrations in mosaic constitution. METHODS: This retrospective multicenter study comprised outcomes of 1562 blastocysts originating from 363 controlled ovarian stimulation cycles, respectively, 226 IVF couples in the period between January 2016 and December 2018. Inclusion criteria were PGT-A cycles with trophectoderm biopsy (TB) and next generation sequencing (NGS). RESULTS: Out of 1562 blastocysts, 25.8% were lost due to non-biopsable and/or non-freezable embryo quality. In 10.3% of all biopsied blastocysts, genetic analysis failed. After exclusion of embryos with uniform or chromosomal aberrations in mosaic, only 18.1% of those originally yielded remained as diagnosed euploid embryos suitable for transfer. This translates into 50.4% of patients and 57.6% of stimulated cycles with no euploid embryo left for transfer. The risk that no transfer can take place rose significantly with a lower number of oocytes and with increasing maternal age. The chance for at least one euploid blastocyst/cycle in advanced maternal age (AMA)-patients was 33.3% compared to 52.1% in recurrent miscarriage (RM), 59.8% in recurrent implantation failure (RIF), and 60.0% in severe male factor (SMF). CONCLUSIONS: The present study demonstrates that PGT-A is accompanied by high embryo drop-out rates. IVF-practitioners should be aware that their patients run a high risk of ending up without any embryo suitable for transfer after (several) stimulation cycles, especially in AMA patients. Patients should be informed in detail about the frequency of inconclusive or mosaic results, with the associated risk of not having an euploid embryo available for transfer after PGT-A, as well as the high cost involved in this type of testing.
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a preimplantační diagnóza $x metody $7 D019836
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a genetické testování $x metody $7 D005820
- 650 _2
- $a blastocysta $x patologie $7 D001755
- 650 _2
- $a aneuploidie $7 D000782
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hrubá, Martina $u Next Fertility IVF Prof. Zech, Smetany 2, 30100, Pilsen, Czech Republic $u Next Lab Genetika, Parková 11a, 32600, Pilsen, Czech Republic
- 700 1_
- $a Schuff, Maximilian $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria
- 700 1_
- $a Hradecký, Libor $u Next Fertility IVF Prof. Zech, Smetany 2, 30100, Pilsen, Czech Republic
- 700 1_
- $a Stecher, Astrid $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria
- 700 1_
- $a Damko, Adriane $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria
- 700 1_
- $a Stadler, Jürgen $u Next Fertility IVF Prof. Zech, Innsbrucker Bundesstrasse 35, 5020, Salzburg, Austria
- 700 1_
- $a Spitzer, Dietmar $u Next Fertility IVF Prof. Zech, Innsbrucker Bundesstrasse 35, 5020, Salzburg, Austria
- 700 1_
- $a Obkircher, Marlene $u Next Fertility Eubios, Fossato Molini 9, 39012, Merano, Italy
- 700 1_
- $a Murtinger, Maximilian $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria $u Next Fertility St. Gallen, Kürsteinerstrasse 2, 9015, St. Gallen, Switzerland
- 773 0_
- $w MED00002533 $t Journal of assisted reproduction and genetics $x 1573-7330 $g Roč. 41, č. 1 (2024), s. 193-203
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37878220 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423160304 $b ABA008
- 999 __
- $a ok $b bmc $g 2081673 $s 1217584
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 41 $c 1 $d 193-203 $e 20231025 $i 1573-7330 $m Journal of assisted reproduction and genetics $n J Assist Reprod Genet $x MED00002533
- LZP __
- $a Pubmed-20240412